Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Exome and regulatory element sequencing of neuromyelitis optica patients.
The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Multiple sclerosis - New treatment modalities.
Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
CNS accumulation of regulatory B cells is VLA-4-dependent.
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.
Gut commensalism, cytokines, and central nervous system demyelination.
Multiple sclerosis in children and adolescents. An important differential diagnosis of acute neurological disease.
Dimethyl fumarat - a new player in oral treatment options for relapsing forms of multiple sclerosis.
[Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs].
Objectification of psychogenic postural instability by trunk sway analysis.
Heterogeneity of root and nerve ultrasound pattern in CIDP patients.
Influence of multiple sclerosis, age and degree of disability, in the position of the contrast sensitivity curve peak.
The relationship between fear of falling to spatiotemporal gait parameters measured by an instrumented treadmill in people with multiple sclerosis.
Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions.
A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy.
Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
CCRL2 regulates M1/M2 polarization during EAE recovery phase.
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception.
Validity and Reliability of the Persian Version of the PERception de la Scle'rose En Plaques et de ses Pousse'es Questionnaire Evaluating Multiple Sclerosis-related Quality of Life.
Monocyte chemoattractant protein-1 promoter -2518 polymorphism and susceptibility to vasculitis, rheumatoid arthritis, and multiple sclerosis: A meta-analysis.
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study.
Evaluation of the humoral response against mycobacterial peptides, homologous to MOG35-55, in multiple sclerosis patients.
Aquaporin-1 Antibody in Neuromyelitis Optica Patients.

Pages